Nano-X Imaging’s (NNOX) Buy Rating Reiterated at D. Boral Capital

D. Boral Capital reiterated their buy rating on shares of Nano-X Imaging (NASDAQ:NNOX) in a research note issued to investors on Tuesday morning,Benzinga reports. The brokerage currently has a $5.00 target price on the stock.

Several other brokerages have also weighed in on NNOX. LADENBURG THALM/SH SH raised Nano-X Imaging to a “strong-buy” rating in a report on Thursday, November 20th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Nano-X Imaging in a research report on Monday, December 29th. Three research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $7.00.

Nano-X Imaging Trading Down 2.3%

NASDAQ:NNOX opened at $2.59 on Tuesday. The stock has a market capitalization of $169.34 million, a PE ratio of -1.96 and a beta of 1.38. The firm’s 50 day moving average is $2.71 and its 200 day moving average is $3.38. Nano-X Imaging has a 12 month low of $2.11 and a 12 month high of $6.39.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Nano-X Imaging by 8.4% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,182 shares of the company’s stock worth $182,000 after buying an additional 2,724 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in Nano-X Imaging by 20.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,433 shares of the company’s stock worth $116,000 after acquiring an additional 3,818 shares during the period. Russell Investments Group Ltd. increased its holdings in Nano-X Imaging by 62.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock worth $51,000 after acquiring an additional 5,283 shares during the period. Gainplan LLC lifted its stake in Nano-X Imaging by 63.1% in the 3rd quarter. Gainplan LLC now owns 18,720 shares of the company’s stock worth $69,000 after purchasing an additional 7,239 shares in the last quarter. Finally, BNP Paribas Financial Markets boosted its holdings in Nano-X Imaging by 64.6% in the 3rd quarter. BNP Paribas Financial Markets now owns 19,743 shares of the company’s stock valued at $73,000 after purchasing an additional 7,749 shares during the period. Hedge funds and other institutional investors own 21.49% of the company’s stock.

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.